The Vanguard Group 13D and 13G filings for Evolent Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Evolent Health, Inc. EVH |
The Vanguard Group | 10,821,331 9.410% |
1,030,515 (+10.53%) |
Filing |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Evolent Health, Inc. EVH |
The Vanguard Group | 9,790,816 9.680% |
2,244,824 (+29.75%) |
Filing |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Evolent Health, Inc. EVH |
The Vanguard Group | 7,545,992 8.440% |
443,328 (+6.24%) |
Filing |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Evolent Health, Inc. EVH |
The Vanguard Group | 7,102,664 8.280% |
216,247 (+3.14%) |
Filing |